{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T20:30:45Z","timestamp":1773952245318,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,2,22]],"date-time":"2015-02-22T00:00:00Z","timestamp":1424563200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s12031-015-0516-7","type":"journal-article","created":{"date-parts":[[2015,2,21]],"date-time":"2015-02-21T06:41:12Z","timestamp":1424500872000},"page":"263-272","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Induction of NQO1 and Neuroprotection by a Novel Compound KMS04014 in Parkinson\u2019s Disease Models"],"prefix":"10.1007","volume":"56","author":[{"given":"Hyo Jin","family":"Son","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Hyun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Ae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kye Jung","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onyou","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,22]]},"reference":[{"key":"516_CR1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF03033137","volume":"5","author":"M Asanuma","year":"2003","unstructured":"Asanuma M, Miyazaki I, Ogawa N (2003) Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease. Neurotox Res 5:165\u2013176","journal-title":"Neurotox Res"},{"key":"516_CR2","doi-asserted-by":"crossref","first-page":"e38026","DOI":"10.1371\/journal.pone.0038026","volume":"7","author":"E Belluzzi","year":"2012","unstructured":"Belluzzi E, Bisaglia M, Lazzarini E, Tabares LC, Beltramini M, Bubacco L (2012) Human SOD2 modification by dopamine quinones affects enzymatic activity by promoting its aggregation: possible implications for Parkinson's disease. PLoS One 7:e38026","journal-title":"PLoS One"},{"issue":"Suppl","key":"516_CR3","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S0098-2997(97)00043-5","volume":"18","author":"RE Beyer","year":"1997","unstructured":"Beyer RE, Segura-Aguilar J, di Bernardo S et al (1997) The two-electron quinone reductase DT-diaphorase generates and maintains the antioxidant (reduced) form of coenzyme Q in membranes. Mol Asp Med 18(Suppl):S15\u2013S23","journal-title":"Mol Asp Med"},{"key":"516_CR4","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.bbadis.2010.06.006","volume":"1802","author":"M Bisaglia","year":"2010","unstructured":"Bisaglia M, Soriano ME, Arduini I, Mammi S, Bubacco L (2010) Molecular characterization of dopamine-derived quinones reactivity toward NADH and glutathione: implications for mitochondrial dysfunction in Parkinson disease. Biochim Biophys Acta 1802:699\u2013706","journal-title":"Biochim Biophys Acta"},{"key":"516_CR5","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/prot.1055","volume":"43","author":"G Cavelier","year":"2001","unstructured":"Cavelier G, Amzel LM (2001) Mechanism of NAD(P)H:quinone reductase: Ab initio studies of reduced flavin. Proteins 43:420\u2013432","journal-title":"Proteins"},{"key":"516_CR6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s12640-009-9078-1","volume":"16","author":"Y Cho","year":"2009","unstructured":"Cho Y, Son HJ, Kim EM et al (2009) Doxycycline is neuroprotective against nigral dopaminergic degeneration by a dual mechanism involving MMP-3. Neurotox Res 16:361\u2013371","journal-title":"Neurotox Res"},{"key":"516_CR7","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1124\/mol.58.3.633","volume":"58","author":"HJ Choi","year":"2000","unstructured":"Choi HJ, Jang YJ, Kim HJ, Hwang O (2000) Tetrahydrobiopterin is released from and causes preferential death of catecholaminergic cells by oxidative stress. Mol Pharmacol 58:633\u2013640","journal-title":"Mol Pharmacol"},{"key":"516_CR8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1471-4159.2003.01808.x","volume":"86","author":"HJ Choi","year":"2003","unstructured":"Choi HJ, Kim SW, Lee SY, Hwang O (2003) Dopamine-dependent cytotoxicity of tetrahydrobiopterin: a possible mechanism for selective neurodegeneration in Parkinson's disease. J Neurochem 86:143\u2013152","journal-title":"J Neurochem"},{"key":"516_CR9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.neuint.2004.10.009","volume":"46","author":"HJ Choi","year":"2005","unstructured":"Choi HJ, Lee SY, Cho Y, Hwang O (2005) Inhibition of vesicular monoamine transporter enhances vulnerability of dopaminergic cells: relevance to Parkinson's disease. Neurochem Int 46:329\u2013335","journal-title":"Neurochem Int"},{"key":"516_CR10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1471-4159.2008.05399.x","volume":"106","author":"DH Choi","year":"2008","unstructured":"Choi DH, Kim EM, Son HJ et al (2008) A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells. J Neurochem 106:405\u2013415","journal-title":"J Neurochem"},{"key":"516_CR11","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.1063522","volume":"294","author":"KA Conway","year":"2001","unstructured":"Conway KA, Rochet JC, Bieganski RM, Lansbury PT Jr (2001) Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 294:1346\u20131349","journal-title":"Science"},{"key":"516_CR12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1471-4159.1998.71010069.x","volume":"71","author":"S Duffy","year":"1998","unstructured":"Duffy S, So A, Murphy TH (1998) Activation of endogenous antioxidant defenses in neuronal cells prevents free radical-mediated damage. J Neurochem 71:69\u201377","journal-title":"J Neurochem"},{"key":"516_CR13","first-page":"59","volume-title":"The mouse brain in stereotaxic coordinates","author":"KBJ Franklin","year":"1997","unstructured":"Franklin KBJ, Paxinos G (1997) The mouse brain in stereotaxic coordinates. Academic Press, San Diego, pp 59\u201367"},{"key":"516_CR14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0300-483X(02)00194-4","volume":"177","author":"S Fujisawa","year":"2002","unstructured":"Fujisawa S, Atsumi T, Kadoma Y, Sakagami H (2002) Antioxidant and prooxidant action of eugenol-related compounds and their cytotoxicity. Toxicology 177:39\u201354","journal-title":"Toxicology"},{"key":"516_CR15","first-page":"3019","volume":"24","author":"S Fujisawa","year":"2004","unstructured":"Fujisawa S, Atsumi T, Kadoma Y, Ishihara M, Ito S, Yokoe I (2004) Kinetic radical scavenging activity and cytotoxicity of 2-methoxy- and 2-t-butyl-substituted phenols and their dimers. Anticancer Res 24:3019\u20133026","journal-title":"Anticancer Res"},{"key":"516_CR16","first-page":"28","volume":"53","author":"S Fujisawa","year":"2005","unstructured":"Fujisawa S, Atsumi T, Murakami Y, Kadoma Y (2005) Dimerization, ROS formation, and biological activity of o-methoxyphenols. Arch Immunol Ther Exp (Warsz) 53:28\u201338","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"516_CR17","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0026-895X(25)13536-0","volume":"14","author":"DG Graham","year":"1978","unstructured":"Graham DG, Tiffany SM, Bell WR Jr, Gutknecht WF (1978) Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol Pharmacol 14:644\u2013653","journal-title":"Mol Pharmacol"},{"key":"516_CR18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1124\/jpet.106.110866","volume":"321","author":"JM Han","year":"2007","unstructured":"Han JM, Lee YJ, Lee SY et al (2007) Protective effect of sulforaphane against dopaminergic cell death. J Pharmacol Exp Ther 321:249\u2013256","journal-title":"J Pharmacol Exp Ther"},{"key":"516_CR19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.molbrainres.2003.08.021","volume":"119","author":"H Hara","year":"2003","unstructured":"Hara H, Ohta M, Ohta K, Kuno S, Adachi T (2003) Increase of antioxidative potential by tert-butylhydroquinone protects against cell death associated with 6-hydroxydopamine-induced oxidative stress in neuroblastoma SH-SY5Y cells. Brain Res Mol Brain Res 119:125\u2013131","journal-title":"Brain Res Mol Brain Res"},{"key":"516_CR20","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1006\/bbrc.2001.5868","volume":"288","author":"S Harada","year":"2001","unstructured":"Harada S, Fujii C, Hayashi A, Ohkoshi N (2001) An association between idiopathic Parkinson's disease and polymorphisms of phase II detoxification enzymes: glutathione S-transferase M1 and quinone oxidoreductase 1 and 2. Biochem Biophys Res Commun 288:887\u2013892","journal-title":"Biochem Biophys Res Commun"},{"key":"516_CR21","first-page":"103","volume":"49","author":"TG Hastings","year":"1997","unstructured":"Hastings TG, Zigmond MJ (1997) Loss of dopaminergic neurons in parkinsonism: possible role of reactive dopamine metabolites. J Neural Transm Suppl 49:103\u2013110","journal-title":"J Neural Transm Suppl"},{"key":"516_CR22","first-page":"849","volume":"19","author":"A Hirata","year":"2005","unstructured":"Hirata A, Murakami Y, Atsumi T et al (2005) Ferulic acid dimer inhibits lipopolysaccharide-stimulated cyclooxygenase-2 expression in macrophages. In Vivo 19:849\u2013853","journal-title":"In Vivo"},{"key":"516_CR23","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/(SICI)1098-2396(199802)28:2<140::AID-SYN4>3.0.CO;2-B","volume":"28","author":"O Hwang","year":"1998","unstructured":"Hwang O, Baker H, Gross S, Joh TH (1998) Localization of GTP cyclohydrolase in monoaminergic but not nitric oxide-producing cells. Synapse 28:140\u2013153","journal-title":"Synapse"},{"key":"516_CR24","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1124\/mol.59.5.1249","volume":"59","author":"O Hwang","year":"2001","unstructured":"Hwang O, Kim G, Jang YJ et al (2001) Synthetic phytoceramides induce apoptosis with higher potency than ceramides. Mol Pharmacol 59:1249\u20131255","journal-title":"Mol Pharmacol"},{"key":"516_CR25","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1006\/bbrc.1994.2544","volume":"204","author":"M Inoue","year":"1994","unstructured":"Inoue M, Suzuki R, Koide T, Sakaguchi N, Ogihara Y, Yabu Y (1994) Antioxidant, gallic acid, induces apoptosis in HL-60RG cells. Biochem Biophys Res Commun 204:898\u2013904","journal-title":"Biochem Biophys Res Commun"},{"key":"516_CR26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1101\/gad.13.1.76","volume":"13","author":"K Itoh","year":"1999","unstructured":"Itoh K, Wakabayashi N, Katoh Y et al (1999) Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 13:76\u201386","journal-title":"Genes Dev"},{"key":"516_CR27","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1089\/ars.2010.3731","volume":"14","author":"A Jazwa","year":"2011","unstructured":"Jazwa A, Rojo AI, Innamorato NG, Hesse M, Fernandez-Ruiz J, Cuadrado A (2011) Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism. Antioxid Redox Signal 14:2347\u20132360","journal-title":"Antioxid Redox Signal"},{"key":"516_CR28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.brainres.2007.12.044","volume":"1197","author":"Z Jia","year":"2008","unstructured":"Jia Z, Zhu H, Misra HP, Li Y (2008) Potent induction of total cellular GSH and NQO1 as well as mitochondrial GSH by 3H-1,2-dithiole-3-thione in SH-SY5Y neuroblastoma cells and primary human neurons: protection against neurocytotoxicity elicited by dopamine, 6-hydroxydopamine, 4-hydroxy-2-nonenal, or hydrogen peroxide. Brain Res 1197:159\u2013169","journal-title":"Brain Res"},{"key":"516_CR29","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1007\/s11064-009-9978-8","volume":"34","author":"Z Jia","year":"2009","unstructured":"Jia Z, Zhu H, Li Y, Misra HP (2009) Cruciferous nutraceutical 3H-1,2-dithiole-3-thione protects human primary astrocytes against neurocytotoxicity elicited by MPTP, MPP(+), 6-OHDA, HNE and acrolein. Neurochem Res 34:1924\u20131934","journal-title":"Neurochem Res"},{"key":"516_CR30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0006-2952(00)00321-X","volume":"60","author":"P Joseph","year":"2000","unstructured":"Joseph P, Long DJ 2nd, Klein-Szanto AJ, Jaiswal AK (2000) Role of NAD(P)H:quinone oxidoreductase 1 (DT diaphorase) in protection against quinone toxicity. Biochem Pharmacol 60:207\u2013214","journal-title":"Biochem Pharmacol"},{"key":"516_CR31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1471-4159.2005.03342.x","volume":"95","author":"ST Kim","year":"2005","unstructured":"Kim ST, Choi JH, Chang JW, Kim SW, Hwang O (2005) Immobilization stress causes increases in tetrahydrobiopterin, dopamine, and neuromelanin and oxidative damage in the nigrostriatal system. J Neurochem 95:89\u201398","journal-title":"J Neurochem"},{"key":"516_CR32","doi-asserted-by":"crossref","first-page":"16444","DOI":"10.1074\/jbc.M109.093799","volume":"285","author":"EM Kim","year":"2010","unstructured":"Kim EM, Shin EJ, Choi JH et al (2010) Matrix metalloproteinase-3 is increased and participates in neuronal apoptotic signaling downstream of caspase-12 during endoplasmic reticulum stress. J Biol Chem 285:16444\u201316452","journal-title":"J Biol Chem"},{"key":"516_CR33","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1128\/MCB.24.16.7130-7139.2004","volume":"24","author":"A Kobayashi","year":"2004","unstructured":"Kobayashi A, Kang MI, Okawa H et al (2004) Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol 24:7130\u20137139","journal-title":"Mol Cell Biol"},{"key":"516_CR34","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/nm1314","volume":"11","author":"MJ LaVoie","year":"2005","unstructured":"LaVoie MJ, Ostaszewski BL, Weihofen A, Schlossmacher MG, Selkoe DJ (2005) Dopamine covalently modifies and functionally inactivates parkin. Nat Med 11:1214\u20131221","journal-title":"Nat Med"},{"key":"516_CR35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.nbd.2006.08.024","volume":"25","author":"SY Lee","year":"2007","unstructured":"Lee SY, Moon Y, Choi DH, Choi HJ, Hwang O (2007) Particular vulnerability of rat mesencephalic dopaminergic neurons to tetrahydrobiopterin: relevance to Parkinson's disease. Neurobiol Dis 25:112\u2013120","journal-title":"Neurobiol Dis"},{"key":"516_CR36","author":"JA Lee","year":"2014","unstructured":"Lee JA, Kim JH, Woo SY et al (2014) A novel compound VSC2 has anti-inflammatory and antioxidant properties in microglia and in Parkinson's disease animal model. Br J Pharmacol. doi: 10.1111\/bph.12973","journal-title":"Br J Pharmacol"},{"key":"516_CR37","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.phrs.2008.03.004","volume":"57","author":"JH Lim","year":"2008","unstructured":"Lim JH, Kim KM, Kim SW, Hwang O, Choi HJ (2008) Bromocriptine activates NQO1 via Nrf2-PI3K\/Akt signaling: novel cytoprotective mechanism against oxidative damage. Pharmacol Res 57:325\u2013331","journal-title":"Pharmacol Res"},{"key":"516_CR38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1248\/bpb.33.29","volume":"33","author":"ZC Ma","year":"2010","unstructured":"Ma ZC, Hong Q, Wang YG et al (2010) Ferulic acid protects human umbilical vein endothelial cells from radiation induced oxidative stress by phosphatidylinositol 3-kinase and extracellular signal-regulated kinase pathways. Biol Pharm Bull 33:29\u201334","journal-title":"Biol Pharm Bull"},{"key":"516_CR39","first-page":"777","volume":"118","author":"M Martinez-Vicente","year":"2008","unstructured":"Martinez-Vicente M, Talloczy Z, Kaushik S et al (2008) Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. J Clin Invest 118:777\u2013788","journal-title":"J Clin Invest"},{"key":"516_CR40","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1016\/j.fct.2010.09.006","volume":"48","author":"DK Maurya","year":"2010","unstructured":"Maurya DK, Devasagayam TP (2010) Antioxidant and prooxidant nature of hydroxycinnamic acid derivatives ferulic and caffeic acids. Food Chem Toxicol 48:3369\u20133373","journal-title":"Food Chem Toxicol"},{"key":"516_CR41","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1096\/fj.05-4996fje","volume":"20","author":"I Miyazaki","year":"2006","unstructured":"Miyazaki I, Asanuma M, Diaz-Corrales FJ et al (2006) Methamphetamine-induced dopaminergic neurotoxicity is regulated by quinone-formation-related molecules. FASEB J 20:571\u2013573","journal-title":"FASEB J"},{"key":"516_CR42","first-page":"2915","volume":"26","author":"Y Murakami","year":"2006","unstructured":"Murakami Y, Shoji M, Ogiwara T, Tanaka S, Yokoe I, Fujisawa S (2006) Preventive effect of ortho dimer of butylated hydroxyanisole on activator protein-1 activation and cyclooxygenase-2 expression in macrophages stimulated by fimbriae of Porphyromonas gingivalis, an oral anaerobe. Anticancer Res 26:2915\u20132920","journal-title":"Anticancer Res"},{"key":"516_CR43","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.brainres.2004.11.054","volume":"1035","author":"LC Schmued","year":"2005","unstructured":"Schmued LC, Stowers CC, Scallet AC, Xu L (2005) Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons. Brain Res 1035:24\u201331","journal-title":"Brain Res"},{"key":"516_CR44","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0014-5793(99)01561-6","volume":"462","author":"E Sergediene","year":"1999","unstructured":"Sergediene E, Jonsson K, Szymusiak H, Tyrakowska B, Rietjens IM, Cenas N (1999) Prooxidant toxicity of polyphenolic antioxidants to HL-60 cells: description of quantitative structure-activity relationships. FEBS Lett 462:392\u2013396","journal-title":"FEBS Lett"},{"key":"516_CR45","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1002\/jnr.21975","volume":"87","author":"A Siebert","year":"2009","unstructured":"Siebert A, Desai V, Chandrasekaran K, Fiskum G, Jafri MS (2009) Nrf2 activators provide neuroprotection against 6-hydroxydopamine toxicity in rat organotypic nigrostriatal cocultures. J Neurosci Res 87:1659\u20131669","journal-title":"J Neurosci Res"},{"key":"516_CR46","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1124\/mol.52.2.300","volume":"52","author":"D Siegel","year":"1997","unstructured":"Siegel D, Bolton EM, Burr JA, Liebler DC, Ross D (1997) The reduction of alpha-tocopherolquinone by human NAD(P)H: quinone oxidoreductase: the role of alpha-tocopherolhydroquinone as a cellular antioxidant. Mol Pharmacol 52:300\u2013305","journal-title":"Mol Pharmacol"},{"key":"516_CR47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1124\/mol.59.2.263","volume":"59","author":"D Siegel","year":"2001","unstructured":"Siegel D, Anwar A, Winski SL, Kepa JK, Zolman KL, Ross D (2001) Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1. Mol Pharmacol 59:263\u2013268","journal-title":"Mol Pharmacol"},{"key":"516_CR48","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1124\/mol.65.5.1238","volume":"65","author":"D Siegel","year":"2004","unstructured":"Siegel D, Gustafson DL, Dehn DL et al (2004) NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger. Mol Pharmacol 65:1238\u20131247","journal-title":"Mol Pharmacol"},{"key":"516_CR49","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1111\/j.1476-5381.2011.01692.x","volume":"165","author":"HJ Son","year":"2012","unstructured":"Son HJ, Lee JA, Shin N et al (2012) A novel compound PTIQ protects the nigral dopaminergic neurones in an animal model of Parkinson's disease induced by MPTP. Br J Pharmacol 165:2213\u20132227","journal-title":"Br J Pharmacol"},{"key":"516_CR50","doi-asserted-by":"crossref","first-page":"854","DOI":"10.2108\/zsj.25.854","volume":"25","author":"BM Thyagaraju","year":"2008","unstructured":"Thyagaraju BM, Muralidhara (2008) Ferulic acid supplements abrogate oxidative impairments in liver and testis in the streptozotocin-diabetic rat. Zool Sci 25:854\u2013860","journal-title":"Zool Sci"},{"key":"516_CR51","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.nbd.2009.03.004","volume":"34","author":"VS Laar Van","year":"2009","unstructured":"Van Laar VS, Mishizen AJ, Cascio M, Hastings TG (2009) Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells. Neurobiol Dis 34:487\u2013500","journal-title":"Neurobiol Dis"},{"key":"516_CR52","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.neurobiolaging.2003.12.010","volume":"25","author":"FL Muiswinkel van","year":"2004","unstructured":"van Muiswinkel FL, de Vos RA, Bol JG et al (2004) Expression of NAD(P)H:quinone oxidoreductase in the normal and Parkinsonian substantia nigra. Neurobiol Aging 25:1253\u20131262","journal-title":"Neurobiol Aging"},{"key":"516_CR53","doi-asserted-by":"crossref","first-page":"14960","DOI":"10.1073\/pnas.93.25.14960","volume":"93","author":"R Venugopal","year":"1996","unstructured":"Venugopal R, Jaiswal AK (1996) Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proc Natl Acad Sci U S A 93:14960\u201314965","journal-title":"Proc Natl Acad Sci U S A"},{"key":"516_CR54","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1007\/s11064-011-0541-z","volume":"36","author":"N Wang","year":"2011","unstructured":"Wang N, Wang Y, Yu G, Yuan C, Ma J (2011) Quinoprotein adducts accumulate in the substantia nigra of aged rats and correlate with dopamine-induced toxicity in SH-SY5Y cells. Neurochem Res 36:2169\u20132175","journal-title":"Neurochem Res"},{"key":"516_CR55","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1021\/jm401788m","volume":"57","author":"SY Woo","year":"2014","unstructured":"Woo SY, Kim JH, Moon MK et al (2014) Discovery of vinyl sulfones as a novel class of neuroprotective agents toward Parkinson's disease therapy. J Med Chem 57:1473\u20131487","journal-title":"J Med Chem"},{"key":"516_CR56","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jnutbio.2008.01.005","volume":"20","author":"CT Yeh","year":"2009","unstructured":"Yeh CT, Ching LC, Yen GC (2009) Inducing gene expression of cardiac antioxidant enzymes by dietary phenolic acids in rats. J Nutr Biochem 20:163\u2013171","journal-title":"J Nutr Biochem"},{"key":"516_CR57","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.toxlet.2006.07.340","volume":"166","author":"KS Zafar","year":"2006","unstructured":"Zafar KS, Inayat-Hussain SH, Siegel D, Bao A, Shieh B, Ross D (2006a) Overexpression of NQO1 protects human SK-N-MC neuroblastoma cells against dopamine-induced cell death. Toxicol Lett 166:261\u2013267","journal-title":"Toxicol Lett"},{"key":"516_CR58","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1124\/mol.106.024703","volume":"70","author":"KS Zafar","year":"2006","unstructured":"Zafar KS, Siegel D, Ross D (2006b) A potential role for cyclized quinones derived from dopamine, DOPA, and 3,4-dihydroxyphenylacetic acid in proteasomal inhibition. Mol Pharmacol 70:1079\u20131086","journal-title":"Mol Pharmacol"},{"key":"516_CR59","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/iub.538","volume":"63","author":"M Zahid","year":"2011","unstructured":"Zahid M, Saeed M, Yang L, Beseler C, Rogan E, Cavalieri EL (2011) Formation of dopamine quinone-DNA adducts and their potential role in the etiology of Parkinson's disease. IUBMB Life 63:1087\u20131093","journal-title":"IUBMB Life"},{"key":"516_CR60","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/10715760902801533","volume":"43","author":"ZD Zhou","year":"2009","unstructured":"Zhou ZD, Lim TM (2009) Dopamine (DA) induced irreversible proteasome inhibition via DA derived quinones. Free Radic Res 43:417\u2013430","journal-title":"Free Radic Res"},{"key":"516_CR61","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1007\/s11064-010-0247-7","volume":"35","author":"ZD Zhou","year":"2010","unstructured":"Zhou ZD, Lim TM (2010) Glutathione conjugates with dopamine-derived quinones to form reactive or non-reactive glutathione-conjugates. Neurochem Res 35:1805\u20131818","journal-title":"Neurochem Res"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-015-0516-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-015-0516-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-015-0516-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T21:25:18Z","timestamp":1747689918000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-015-0516-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,22]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["516"],"URL":"https:\/\/doi.org\/10.1007\/s12031-015-0516-7","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,22]]}}}